Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1999 1
2000 1
2001 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.
Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL. Stoffel MP, et al. Clin Exp Immunol. 1996 Apr;104(1):54-9. doi: 10.1046/j.1365-2249.1996.d01-654.x. Clin Exp Immunol. 1996. PMID: 8603534 Free PMC article.
BPI-ANCA were found to be closely associated with IBD and primary sclerosing cholangitis (34% and 44% of ANCA-positive sera, respectively). ...BPI-ANCA appear to constitute an important marker for IBD and primary sclerosing chol
BPI-ANCA were found to be closely associated with IBD and primary sclerosing cholangitis (34% and 44% of ANCA-po
[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
Schnabel A, Csernok E, Schultz H, Stoffel M, Herzberg C, Carroll SF, Gross WL. Schnabel A, et al. Med Klin (Munich). 1997 Jul 15;92(7):389-93. doi: 10.1007/BF03042568. Med Klin (Munich). 1997. PMID: 9324622 German.
The clinical associations of autoantibodies against BPI (BPI-ANCA) are essentially unclear. PATIENTS AND METHODS: 587 sera from patients with chronic inflammatory bowel diseases, inflammatory hepatobiliary diseases, primary systemic vasculitides and other rhe …
The clinical associations of autoantibodies against BPI (BPI-ANCA) are essentially unclear. PATIENTS AND METHODS: 587 sera fro …
The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H, Weiss J, Carroll SF, Gross WL. Schultz H, et al. J Leukoc Biol. 2001 Apr;69(4):505-12. J Leukoc Biol. 2001. PMID: 11310835 Review.
BPI is also a target antigen of anti-neutrophil cytoplasmic autoantibodies (ANCA). BPI-ANCA are present in cystic fibrosis, inflammatory bowel disease, vasculitis, and primary sclerosing cholangitis; presence of BPI-ANCA appears associate
BPI is also a target antigen of anti-neutrophil cytoplasmic autoantibodies (ANCA). BPI-ANCA are present in cystic fibrosis, in
Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S, Nilsson S, Nässberger L, Verbaan H, Wieslander J. Lindgren S, et al. J Gastroenterol Hepatol. 2000 Apr;15(4):437-42. doi: 10.1046/j.1440-1746.2000.02078.x. J Gastroenterol Hepatol. 2000. PMID: 10824890
BACKGROUND: Anti-neutrophil cytoplasmic antibodies (ANCA) against proteinase 3 are diagnostic of Wegener's granulomatosis, but ANCA occur also in patients with other inflammatory disorders, such as ulcerative colitis, primary sclerosing cholangitis (PSC) and …
BACKGROUND: Anti-neutrophil cytoplasmic antibodies (ANCA) against proteinase 3 are diagnostic of Wegener's granulomatosis, but ANCA occur al …
Anti-neutrophil cytoplasmic autoantibodies (ANCA) to bactericidal/permeability-increasing (BPI) protein recognize the carboxyl terminal domain.
Dunn AC, Walmsley RS, Dedrick RL, Wakefield AJ, Lockwood CM. Dunn AC, et al. J Infect. 1999 Jul;39(1):81-7. doi: 10.1016/s0163-4453(99)90107-x. J Infect. 1999. PMID: 10468134
OBJECTIVES: to identify the region of bactericidal/permeability-increasing protein (BPI) recognized by anti-BPI ANCA. METHODS: sera from 140 patients with a variety of clinical diagnoses (20 systemic vasculitis, 12 cystic fibrosis, 22 bronchiectasis/chronic obstruct …
OBJECTIVES: to identify the region of bactericidal/permeability-increasing protein (BPI) recognized by anti-BPI ANCA. METHODS: …
Feedback